Haematology & OncologyVideo lectures2026
Scripps Clinical Hematology and Oncology 2026 — thrombosis, myeloma, lymphoma and solid tumours in one programme
Scripps Clinical Hematology and Oncology 2026 is the latest recording of Scripps Cancer Center’s annual West Coast meeting, one of the few that gives benign haematology, blood cancers and solid tumours equal billing. You get 42 videos: anti-PF4 disorders, ITP and transfusion open the programme, four case breakouts follow, and the later days move through AML, MDS, relapsed myeloma, lymphoma, amyloidosis, breast, lung, GI, head and neck, gynaecologic and brain tumours before closing on bone health and skin toxicity.
- 42videos
- 10panel Q&As
- 4case breakouts
- 2026edition
What you’ll be able to do
- Recognise platelet-activating anti-PF4 disorders and unusual thromboses early
- Decide when anticoagulant and antiplatelet therapy should, or should not, be combined
- Place menin inhibitors, hypomethylating agents and post-CD38 myeloma options in sequence
- Weigh ctDNA and MRD monitoring in breast cancer against the current evidence
- Choose between chemo-immunotherapy and immunotherapy alone in metastatic NSCLC
- Protect bone health and skin during and after cancer treatment
Inside the course
Bleeding, clotting and platelets
The haematology morning covers ITP in 2026, transfusion practice for the office-based haematologist-oncologist, unusual clot sites and a VTE update. Breakouts then work through real cases in thrombosis, platelet disorders, bleeding and plasma cell dyscrasias.
Scripps Clinical Hematology and Oncology on blood cancers
Talks on targeted AML therapy, MDS beyond azacitidine-type agents, relapsed myeloma after the standard drug classes, refractory large cell and mantle cell lymphoma, and AL amyloidosis, each group followed by panel discussion.
Melanoma through a three-speaker lens
Janice Mehnert, Ryan Sullivan and Allison Betof-Warner split the melanoma session from neoadjuvant therapy to refractory disease, including novel agents and immune-related adverse events.
Solid tumours and survivorship
Moderate-penetrance breast cancer genes, metastatic triple-negative disease, resectable and EGFR-mutant lung cancer, GI checkpoint therapy, pancreatic cancer, HPV-positive head and neck de-escalation, cervical cancer and molecular brain tumour classification lead to the supportive-care finale.
Built for
- Community haematologist-oncologistsA single meeting spans both halves of a mixed practice.
- Internists and hospitalistsThe thrombosis and platelet blocks answer frequent inpatient consult questions.
- Oncology NPs and PAsPanels and breakouts show how experts reason through everyday cases.
Faculty & syllabus
Sessions in programme order 42 videos
- 01 — Platelet-Activating Anti-PF4 Disorders
- 02 — ITP 2026 Update
- 03 — Transfusion Medicine for the Practicing Hem-Onc Physician
- 04 — Panel Discussion/Q&A
- 05 — Unusual Thromboses
- 06 — Anticoagulants and Antiplatelet Agents When to Combine and When not to
- 07 — VTE and Anticoagulation 2026 Update
- 08 — Panel Discussion/Q&A
- 09 — Breakout 1 Interesting Cases in Thrombosis
- 10 — Breakout 2 Interesting Cases in Platelet Disorders
- 11 — Breakout 3 Interesting Cases in Bleeding
- 12 — Breakout 4 Interesting Cases in Plasma Cell Dyscrasias
- Janice Mehnert, MD — 13 Melanoma From Neo-Adjuvant Therapy to Refractory Disease Immune Therapy, Novel Agents, and Managing irAEs
- Ryan Sullivan, MD — 13 Melanoma From Neo-Adjuvant Therapy to Refractory Disease Immune Therapy, Novel Agents, and Managing irAEs
- Allison Betof-Warner, MD, PhD — 13 Melanoma From Neo-Adjuvant Therapy to Refractory Disease Immune Therapy, Novel Agents, and Managing irAEs
- 14 — Panel Discussion/Q&A
- 15 — Menin Inhibitors and Other New Targeted Therapies in AML
- 16 — Hypomethylating Agents and Beyond Cutting-Edge Approaches to MDS
- 17 — After IMiDs, Proteosome Inhibitors, and CD38 Antibodies Novel Approaches to Relapsed/Refractory Multiple Myeloma
- 18 — Panel Discussion/Q&A
- 19 — Newer Therapeutic Options for Refractory or Relapsed Large Cell Lymphoma
- 20 — Non-Chemotherapy Approaches to Mantle Cell Lymphoma
- 21 — Progress in the Treatment of AL Amyloidosis
- 22 — Panel Discussion/Q&A
- 23 — Beyond BRCA Managing Risk in Women with Moderate-Penetrance Gene Mutations
- 24 — Advances in the Treatment of Metastatic Triple-Negative Breast Cancer
- 25 — Minimal Residual Disease, Disease Monitoring, and Therapy Selection What is the Evidence-Based role for ctDNA in Breast Cancer Therapy
- 26 — Panel Discussion/Q&A
- 27 — Neo-Adjuvant Chemo-Immunotherapy in Resectable NSCLC A New Standard of Care
- 28 — Therapy Beyond First-Line Therapy in EGFR Mutated NSCLC
- 29 — Comparing the Harms and Benefits of Chemo-Immunotherapy or Immunotherapy Alone in the Metastatic Setting
- 30 — Panel Discussion/Q&A
- 31 — Checkpoint Immune Therapy in the Curative Settings of GI Cancers
- 32 — Are TTFs and Novel Small Molecules Moving the Needle in Pancreatic Cancer
- 33 — Panel Discussion/Q&A
- 34 — De-Escalation Strategies in HPV Positive Head and Neck Cancer
- 35 — Cervical Cancer Updates
- 36 — Molecular Classification and Treatment Opportunities in Brain Tumors
- 37 — Panel Discussion/Q&A
- 38 — Optimizing Bone Health in Cancer Care During and After Treatment
- 39 — Management of Common Skin Related Side Effects During and After Cancer Treatment
- 40 — Panel Discussion/Q&A
Before you buy
Are slides or a syllabus PDF included?
No. This 2026 release is 42 videos only; no PDF handouts come with it, even though the product label mentions PDFs.
Who is speaking in each session?
Speaker names are given only for the three melanoma talks; the other titles were supplied without faculty. The file size was not stated either.
How does it differ from the 2025 meeting?
The programme is new. Scripps Clinical Hematology and Oncology 2025 (MS-29907) is sold separately with 41 videos, a PDF and named faculty.
Do I get CME credit or a certificate?
No. Clinicapedia provides the educational content only — no CME or CE credits, MOC points or certificates of completion are included with this product.
Specifications
| Format | Videos (no PDFs) |
|---|---|
| Contents | 42 videos, incl. 10 panels and 4 breakouts |
| Edition | 2026 |
| Publisher | Scripps Health |
| Department | Oncology |
| Delivery | Instant download · lifetime re-download |
Related products
Harvard Medicine
Oncology-Hematology
Cleveland Clinic Basic & Clinical Immunology for the Busy Clinician 2025
Oncology-Hematology
The Brigham and Dana-Farber Board Review and Comprehensive Update in Oncology 2025 (Videos + Slides)
Cardiology
Anesthesiology
Harvard Medicine
